Skip to main content
PMC home page
Sexually Transmitted Infections logoLink to Sexually Transmitted Infections
. 1999 Aug;75(4):247–252. doi: 10.1136/sti.75.4.247

Survival and progression of HIV disease in women attending GUM/HIV clinics in Britain and Ireland. Study Group for the MRC Collaborative Study of HIV Infection in Women

PMCID: PMC1758227  PMID: 10615311

Abstract

OBJECTIVES: To describe the pattern of clinical disease in women with HIV infection and to examine the effect of potential cofactors, including oral contraceptive use, alcohol and smoking, ethnic group, and route of HIV transmission, on progression to AIDS and death. DESIGN: Prospective observational cohort study. SETTING: 15 HIV and genitourinary medicine (GUM) clinics in Britain and Ireland. PARTICIPANTS: 505 women aged over 18 years with a positive HIV antibody test entered the study between June 1992 and August 1995, with outcome data available for 503 women, and 1208 woman years of follow up to April 1996. MAIN OUTCOME MEASURES: AIDS defining conditions, incidence of AIDS, and death. RESULTS: 120 women (24%) had AIDS at entry to the study. There were 99 incident AIDS cases and 132 deaths during 1208 woman years of follow up. Pneumocystis carinii pneumonia (PCP) was the commonest first AIDS defining condition in white women (31% of AIDS cases), followed by oesophageal candidiasis (19%) while tuberculosis was the most common first AIDS defining condition among black African women (24% of AIDS cases), followed by oesophageal candidiasis (19%). In multivariate analyses, rate of progression to AIDS was significantly related to CD4 lymphocyte count at entry and PCP prophylaxis, but not to ethnic group, route of HIV transmission, alcohol, smoking, or oral contraceptive use. Mortality from all causes was not significantly different in women infected through injecting drugs (adjusted ratio 1.1, 95% confidence interval 0.7-1.8) compared with those infected through sexual intercourse, and non-significantly lower in black African women (0.7, 0.3-1.2) compared with white women. Survival was not significantly related to smoking, alcohol, or oral contraceptive use. CONCLUSIONS: In women attending GUM/HIV clinics, the pattern of AIDS defining conditions differs by ethnic group, but progression of HIV disease is not importantly related to smoking, alcohol, oral contraceptive use, route of HIV transmission, or ethnic group. 




Full Text

The Full Text of this article is available as a PDF (107.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Burns D. N., Hillman D., Neaton J. D., Sherer R., Mitchell T., Capps L., Vallier W. G., Thurnherr M. D., Gordin F. M. Cigarette smoking, bacterial pneumonia, and other clinical outcomes in HIV-1 infection. Terry Beirn Community Programs for Clinical Research on AIDS. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Dec 1;13(4):374–383. doi: 10.1097/00042560-199612010-00012. [DOI] [PubMed] [Google Scholar]
  2. Chaisson R. E., Keruly J. C., Moore R. D. Race, sex, drug use, and progression of human immunodeficiency virus disease. N Engl J Med. 1995 Sep 21;333(12):751–756. doi: 10.1056/NEJM199509213331202. [DOI] [PubMed] [Google Scholar]
  3. Clark R. A., Bessinger R. Clinical manifestations and predictors of survival in older women infected with HIV. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Aug 15;15(5):341–345. doi: 10.1097/00042560-199708150-00003. [DOI] [PubMed] [Google Scholar]
  4. Clark R. A., Blakley S. A., Rice J., Brandon W. Predictors of HIV disease progression in women. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 May 1;9(1):43–50. [PubMed] [Google Scholar]
  5. Cozzi Lepri A., Pezzotti P., Dorrucci M., Phillips A. N., Rezza G. HIV disease progression in 854 women and men infected through injecting drug use and heterosexual sex and followed for up to nine years from seroconversion. Italian Seroconversion Study. BMJ. 1994 Dec 10;309(6968):1537–1542. doi: 10.1136/bmj.309.6968.1537. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Craib K. J., Schechter M. T., Montaner J. S., Le T. N., Sestak P., Willoughby B., Voigt R., Haley L., O'Shaughnessy M. V. The effect of cigarette smoking on lymphocyte subsets and progression to AIDS in a cohort of homosexual men. Clin Invest Med. 1992 Aug;15(4):301–308. [PubMed] [Google Scholar]
  7. Darby S. C., Ewart D. W., Giangrande P. L., Spooner R. J., Rizza C. R. Importance of age at infection with HIV-1 for survival and development of AIDS in UK haemophilia population. UK Haemophilia Centre Directors' Organisation. Lancet. 1996 Jun 8;347(9015):1573–1579. doi: 10.1016/s0140-6736(96)91073-9. [DOI] [PubMed] [Google Scholar]
  8. Del Amo J., Petruckevitch A., Phillips A., Johnson A. M., Stephenson J., Desmond N., Hanscheid T., Low N., Newell A., Obasi A. Disease progression and survival in HIV-1-infected Africans in London. AIDS. 1998 Jul 9;12(10):1203–1209. doi: 10.1097/00002030-199810000-00013. [DOI] [PubMed] [Google Scholar]
  9. Gazzard B., Moyle G. 1998 revision to the British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals. BHIVA Guidelines Writing Committee. Lancet. 1998 Jul 25;352(9124):314–316. doi: 10.1016/s0140-6736(98)04084-7. [DOI] [PubMed] [Google Scholar]
  10. Hogg R. S., Heath K. V., Yip B., Craib K. J., O'Shaughnessy M. V., Schechter M. T., Montaner J. S. Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. JAMA. 1998 Feb 11;279(6):450–454. doi: 10.1001/jama.279.6.450. [DOI] [PubMed] [Google Scholar]
  11. Hogg R. S., Strathdee S. A., Craib K. J., O'Shaughnessy M. V., Montaner J. S., Schechter M. T. Lower socioeconomic status and shorter survival following HIV infection. Lancet. 1994 Oct 22;344(8930):1120–1124. doi: 10.1016/s0140-6736(94)90631-9. [DOI] [PubMed] [Google Scholar]
  12. Lee C. A., Phillips A. N., Elford J., Janossy G., Griffiths P., Kernoff P. Progression of HIV disease in a haemophilic cohort followed for 11 years and the effect of treatment. BMJ. 1991 Nov 2;303(6810):1093–1096. doi: 10.1136/bmj.303.6810.1093. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Lindan C. P., Allen S., Serufilira A., Lifson A. R., Van de Perre P., Chen-Rundle A., Batungwanayo J., Nsengumuremyi F., Bogaerts J., Hulley S. Predictors of mortality among HIV-infected women in Kigali, Rwanda. Ann Intern Med. 1992 Feb 15;116(4):320–328. doi: 10.7326/0003-4819-116-4-320. [DOI] [PubMed] [Google Scholar]
  14. Maini M. K., Gilson R. J., Chavda N., Gill S., Fakoya A., Ross E. J., Phillips A. N., Weller I. V. Reference ranges and sources of variability of CD4 counts in HIV-seronegative women and men. Genitourin Med. 1996 Feb;72(1):27–31. doi: 10.1136/sti.72.1.27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Mellors J. W., Muñoz A., Giorgi J. V., Margolick J. B., Tassoni C. J., Gupta P., Kingsley L. A., Todd J. A., Saah A. J., Detels R. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med. 1997 Jun 15;126(12):946–954. doi: 10.7326/0003-4819-126-12-199706150-00003. [DOI] [PubMed] [Google Scholar]
  16. Melnick S. L., Sherer R., Louis T. A., Hillman D., Rodriguez E. M., Lackman C., Capps L., Brown L. S., Jr, Carlyn M., Korvick J. A. Survival and disease progression according to gender of patients with HIV infection. The Terry Beirn Community Programs for Clinical Research on AIDS. JAMA. 1994 Dec 28;272(24):1915–1921. [PubMed] [Google Scholar]
  17. Mercey D., Griffioen A., Woronowski H., Stephenson J. Uptake of medical interventions in women with HIV infection in Britain and Ireland. Study Group for the MRC Collaborative Study of HIV Infection in Women. Genitourin Med. 1996 Aug;72(4):281–282. doi: 10.1136/sti.72.4.281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Morlat P., Parneix P., Douard D., Lacoste D., Dupon M., Chêne G., Pellegrin J. L., Ragnaud J. M., Dabis F. Women and HIV infection: a cohort study of 483 HIV-infected women in Bordeaux, France, 1985-1991. The Groupe d'Epidémiologie Clinique du SIDA en Aquitaine. AIDS. 1992 Oct;6(10):1187–1193. [PubMed] [Google Scholar]
  19. Mulder D. W., Nunn A. J., Kamali A., Nakiyingi J., Wagner H. U., Kengeya-Kayondo J. F. Two-year HIV-1-associated mortality in a Ugandan rural population. Lancet. 1994 Apr 23;343(8904):1021–1023. doi: 10.1016/s0140-6736(94)90133-3. [DOI] [PubMed] [Google Scholar]
  20. Pezzotti P., Phillips A. N., Dorrucci M., Lepri A. C., Galai N., Vlahov D., Rezza G. Category of exposure to HIV and age in the progression to AIDS: longitudinal study of 1199 people with known dates of seroconversion. HIV Italian Seroconversion Study Group. BMJ. 1996 Sep 7;313(7057):583–586. doi: 10.1136/bmj.313.7057.583. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Prins M., Veugelers P. J. Comparison of progression and non-progression in injecting drug users and homosexual men with documented dates of HIV-1 seroconversion. European Seroconverter Study and the Tricontinental Seroconverter Study. AIDS. 1997 Apr;11(5):621–631. doi: 10.1097/00002030-199705000-00010. [DOI] [PubMed] [Google Scholar]
  22. Rutherford G. W., Lifson A. R., Hessol N. A., Darrow W. W., O'Malley P. M., Buchbinder S. P., Barnhart J. L., Bodecker T. W., Cannon L., Doll L. S. Course of HIV-I infection in a cohort of homosexual and bisexual men: an 11 year follow up study. BMJ. 1990 Nov 24;301(6762):1183–1188. doi: 10.1136/bmj.301.6762.1183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Selwyn P. A., Alcabes P., Hartel D., Buono D., Schoenbaum E. E., Klein R. S., Davenny K., Friedland G. H. Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection. N Engl J Med. 1992 Dec 10;327(24):1697–1703. doi: 10.1056/NEJM199212103272401. [DOI] [PubMed] [Google Scholar]
  24. Sha B. E., Benson C. A., Pottage J. C., Jr, Urbanski P. A., Daugherty S. R., Kessler H. A. HIV infection in women: an observational study of clinical characteristics, disease progression, and survival for a cohort of women in Chicago. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Apr 15;8(5):486–495. [PubMed] [Google Scholar]
  25. Smith D. K., Warren D. L., Vlahov D., Schuman P., Stein M. D., Greenberg B. L., Holmberg S. D. Design and baseline participant characteristics of the Human Immunodeficiency Virus Epidemiology Research (HER) Study: a prospective cohort study of human immunodeficiency virus infection in US women. Am J Epidemiol. 1997 Sep 15;146(6):459–469. doi: 10.1093/oxfordjournals.aje.a009299. [DOI] [PubMed] [Google Scholar]
  26. Stephenson J. M. Systematic review of hormonal contraception and risk of HIV transmission: when to resist meta-analysis. AIDS. 1998 Apr 16;12(6):545–553. doi: 10.1097/00002030-199806000-00002. [DOI] [PubMed] [Google Scholar]
  27. Sterk C. E. Women and AIDS: a brief update. Int J STD AIDS. 1998;9 (Suppl 1):16–18. doi: 10.1258/0956462981921611. [DOI] [PubMed] [Google Scholar]
  28. Ward J. W., Bush T. J., Perkins H. A., Lieb L. E., Allen J. R., Goldfinger D., Samson S. M., Pepkowitz S. H., Fernando L. P., Holland P. V. The natural history of transfusion-associated infection with human immunodeficiency virus. Factors influencing the rate of progression to disease. N Engl J Med. 1989 Oct 5;321(14):947–952. doi: 10.1056/NEJM198910053211406. [DOI] [PubMed] [Google Scholar]
  29. von Overbeck J., Egger M., Smith G. D., Schoep M., Ledergerber B., Furrer H., Malinverni R. Survival in HIV infection: do sex and category of transmission matter? Swiss HIV Cohort Study. AIDS. 1994 Sep;8(9):1307–1313. doi: 10.1097/00002030-199409000-00014. [DOI] [PubMed] [Google Scholar]

Articles from Sexually Transmitted Infections are provided here courtesy of BMJ Publishing Group

RESOURCES